Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

Emily G Severance, Kristin L. Gressitt, Catherine R. Stallings, Emily Katsafanas, Lucy A. Schweinfurth, Christina L. Savage, Maria B. Adamos, Kevin M. Sweeney, Andrea E. Origoni, Sunil Khushalani, F. Markus Leweke, Faith B. Dickerson, Robert H Yolken

Research output: Contribution to journalArticle

Abstract

Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.

Original languageEnglish (US)
Article numbernpjschz201618
Journalnpj Schizophrenia
Volume2
DOIs
StatePublished - May 4 2016

Fingerprint

Candida albicans
Bipolar Disorder
Schizophrenia
Psychiatry
Odds Ratio
Antipsychotic Agents
Immunoglobulin G
Homeless Persons
Cognition
Life Style
Yeasts
Antibodies
Brain
Infection

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder. / Severance, Emily G; Gressitt, Kristin L.; Stallings, Catherine R.; Katsafanas, Emily; Schweinfurth, Lucy A.; Savage, Christina L.; Adamos, Maria B.; Sweeney, Kevin M.; Origoni, Andrea E.; Khushalani, Sunil; Leweke, F. Markus; Dickerson, Faith B.; Yolken, Robert H.

In: npj Schizophrenia, Vol. 2, npjschz201618, 04.05.2016.

Research output: Contribution to journalArticle

Severance, EG, Gressitt, KL, Stallings, CR, Katsafanas, E, Schweinfurth, LA, Savage, CL, Adamos, MB, Sweeney, KM, Origoni, AE, Khushalani, S, Leweke, FM, Dickerson, FB & Yolken, RH 2016, 'Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder', npj Schizophrenia, vol. 2, npjschz201618. https://doi.org/10.1038/npjschz.2016.18
Severance, Emily G ; Gressitt, Kristin L. ; Stallings, Catherine R. ; Katsafanas, Emily ; Schweinfurth, Lucy A. ; Savage, Christina L. ; Adamos, Maria B. ; Sweeney, Kevin M. ; Origoni, Andrea E. ; Khushalani, Sunil ; Leweke, F. Markus ; Dickerson, Faith B. ; Yolken, Robert H. / Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder. In: npj Schizophrenia. 2016 ; Vol. 2.
@article{8fb325090cb14b23a85755e659c47dc7,
title = "Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder",
abstract = "Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.",
author = "Severance, {Emily G} and Gressitt, {Kristin L.} and Stallings, {Catherine R.} and Emily Katsafanas and Schweinfurth, {Lucy A.} and Savage, {Christina L.} and Adamos, {Maria B.} and Sweeney, {Kevin M.} and Origoni, {Andrea E.} and Sunil Khushalani and Leweke, {F. Markus} and Dickerson, {Faith B.} and Yolken, {Robert H}",
year = "2016",
month = "5",
day = "4",
doi = "10.1038/npjschz.2016.18",
language = "English (US)",
volume = "2",
journal = "npj Schizophrenia",
issn = "2334-265X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

AU - Severance, Emily G

AU - Gressitt, Kristin L.

AU - Stallings, Catherine R.

AU - Katsafanas, Emily

AU - Schweinfurth, Lucy A.

AU - Savage, Christina L.

AU - Adamos, Maria B.

AU - Sweeney, Kevin M.

AU - Origoni, Andrea E.

AU - Khushalani, Sunil

AU - Leweke, F. Markus

AU - Dickerson, Faith B.

AU - Yolken, Robert H

PY - 2016/5/4

Y1 - 2016/5/4

N2 - Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.

AB - Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=85029851224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029851224&partnerID=8YFLogxK

U2 - 10.1038/npjschz.2016.18

DO - 10.1038/npjschz.2016.18

M3 - Article

AN - SCOPUS:85029851224

VL - 2

JO - npj Schizophrenia

JF - npj Schizophrenia

SN - 2334-265X

M1 - npjschz201618

ER -